Sign inJoin waitlistJoin the waitlist

PO

Pedro Oyuela

Credentials:

History

Residency
2008–2011
Medical School
2004–2008

Research

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
The Lancet · 2012 · 924 citations
Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis
The Journal of Clinical Endocrinology & Metabolism · 2014 · 120 citations
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
Blood · 2011 · 77 citations

DM
David Margolin
5 papers
EF
Edward Fox
2 papers
FV
Frank Valone
2 papers
Abdulraheem Yacoub
1 paper
Adam Cuker
1 paper
AM
Alina Markova
1 paper
AK
Andrew Kuykendall
1 paper
CT
Cary Twyman
1 paper
DB
Diana Beardsley
1 paper
GD
Gilbert Daniels
1 paper
HW
Howard Weiner
1 paper
Jeffrey Cohen
1 paper